Omics Lab Services Market Size & Growth Forecast 2027–2036, By Segments (Product, Services, End-Use, Business, Frequency of Service), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Omics Lab Services Market size was over USD 108.65 billion in 2026 and is likely to grow at a 12.15% CAGR between 2027 and 2036, crossing USD 342 billion by 2036. The industry revenue for 2027 is assessed at USD 121.12 billion.
Get more details on this report
Request Free Sample ReportOmics Lab Services Market Intelligence Snapshot
Regional Market Dynamics
- North America leads through established laboratory infrastructure, advanced sequencing platforms, and strong demand from pharmaceutical companies, research institutions, and healthcare organizations requiring specialized omics services.
- Asia Pacific is expected to grow at a 15.12% CAGR as precision medicine adoption, biotechnology research, and outsourcing of specialized omics testing continue to expand across the region.
Segment Momentum
- Repeat services lead the market because ongoing research programs require consistent testing across multiple sample batches and validation cycles, supporting steady laboratory utilization and client retention.
- Epigenetics is expanding fastest as researchers increasingly seek insights into gene regulation and disease-related biological changes beyond sequence analysis, driving wider adoption of specialized services.
Market Expansion Drivers
- Increasing adoption of genomics and NGS technologies driving outsourced omics laboratory service demand.
- Expanding oncology research and ctDNA analysis accelerating clinical omics integration in precision medicine.
- Growing AI-enabled bioinformatics capabilities improving large-scale omics data interpretation and workflow efficiency.
Leading Market Participants
- Top companies in the omics lab services market include Thermo Fisher Scientific Inc. (United States), Illumina, Inc. (United States), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (United States), Quest Diagnostics Incorporated (United States), BGI Genomics Co., Ltd. (China), Laboratory Corporation of America Holdings (United States), Eurofins Scientific SE (Luxembourg), Q² Solutions (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 108.65 billion
- 2027 Estimated Market Size: USD 121.12 billion.
- Projected Market Size: USD 342 billion by 2036
- Growth Forecast: 12.15% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Repeat (Product) | Genomics (Services) | Hardware Equipment (Instrument, Kits, Chips) (End-Use) | Cancer (Business) | Research Institutes (Frequency of Service)
- Emerging Opportunity Segment: One-off (Product) | Epigenetics (Services) | Analytics / Interpretation (Personalization and Interpretation) (End-Use) | Skincare (Business) | Diagnostic Labs (Frequency of Service)
Market Growth Drivers and Industry Trends
Increasing adoption of genomics and NGS technologies driving outsourced omics laboratory service demand
Wider use of genomics and next-generation sequencing is generating complex laboratory requirements that encourage organizations to rely on specialized external capabilities. The omics lab services market will benefit as research and healthcare users seek outsourced testing, sequencing, and analytical expertise to manage growing omics workflows without relying entirely on in-house laboratory infrastructure.
Expanding oncology research and ctDNA analysis accelerating clinical omics integration in precision medicine
Advances in oncology research are increasing the use of molecular information to support more targeted approaches to cancer investigation and treatment. In the omics lab services market, growing adoption of circulating tumor DNA analysis is strengthening demand for specialized clinical omics capabilities that can support precision medicine workflows and cancer-focused research activities.
Growing AI-enabled bioinformatics capabilities improving large-scale omics data interpretation and workflow efficiency
The increasing integration of artificial intelligence into bioinformatics is improving the ability to process and interpret large volumes of omics information. As these capabilities mature, the omics lab services market can support more efficient analytical workflows by applying advanced computational tools to complex datasets and reducing the operational burden associated with large-scale data interpretation.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising demand for multi-omics research integration | 5.20% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | High | Fast |
| Expansion of clinical & translational omics services | 4.60% | Medium term (2–5 yrs) | Asia Pacific, North America (spillover: Europe) | Medium | Moderate |
| Advances in cloud-based analytics & data sharing | 3.70% | Long term (5+ yrs) | Europe, Asia Pacific (spillover: North America) | Medium | Slow |
| Increasing adoption of genomics and NGS technologies driving outsourced omics laboratory service demand | 2.20% | High | North America, Europe | High | Near Term |
| Expanding oncology research and ctDNA analysis accelerating clinical omics integration in precision medicine | 1.90% | High | North America, Asia Pacific | High | Mid Term |
| Growing AI-enabled bioinformatics capabilities improving large-scale omics data interpretation and workflow efficiency | 1.60% | Moderate | Europe, Asia Pacific | Emerging | Long Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
The omics lab services market was led by North America in 2026, supported by a mature life sciences ecosystem, advanced laboratory infrastructure, and strong demand for genomics, proteomics, metabolomics, and other high-throughput analytical services. Research institutions, pharmaceutical organizations, biotechnology developers, and healthcare providers are increasingly using specialized laboratory services to generate detailed biological insights for drug discovery, disease research, biomarker identification, and precision medicine. Strong investment in research infrastructure and advanced sequencing and analytical technologies is strengthening the region's capabilities. The growing integration of multi-omics approaches into biomedical research is also expanding demand for specialized laboratory expertise and data interpretation services.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing regional market, driven by expanding biotechnology research, increasing healthcare investment, and growing adoption of advanced genomic and molecular analysis. Pharmaceutical and academic research activity is creating broader demand for outsourced laboratory capabilities that can support complex biological studies without requiring extensive in-house infrastructure. Improvements in sequencing technologies, laboratory facilities, and research expertise are making sophisticated omics services increasingly accessible. Growing interest in precision medicine and biomarker-driven healthcare is further encouraging the use of genomic and molecular data in research and clinical applications. As regional life sciences capabilities continue to mature, demand for specialized omics laboratory services is gaining momentum.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Research Collaboration HubGermany strengthens omics lab services through partnerships between academic institutions, pharmaceutical companies, and contract laboratories. Service providers emphasize high-quality analytical workflows, standardized data generation, and reproducible research outcomes.
France 🇫🇷
Clinical Research IntegrationFrance leverages omics lab services to strengthen translational research and clinical study programs. Laboratories prioritize harmonized analytical methods and comprehensive data interpretation to support healthcare and life sciences innovation.
Italy 🇮🇹
Academic Genomics SupportItaly maintains demand for omics lab services through collaborative research across universities, hospitals, and biotechnology organizations. Providers focus on accessible analytical expertise, quality data generation, and flexible service offerings for diverse research projects.
Japan 🇯🇵
Precision Medicine AnalyticsJapan prioritizes omics lab services that support biomarker discovery and personalized healthcare research. Laboratories invest in advanced sequencing and analytical platforms to deliver reliable multi-omics datasets for clinical and pharmaceutical applications.
South Korea 🇰🇷
Bioinformatics Capability GrowthSouth Korea expands omics lab services by combining sequencing expertise with advanced computational analysis. Service providers increasingly offer integrated bioinformatics solutions that help biotechnology and pharmaceutical companies accelerate research programs.
United States 🇺🇸
Multi-Omics Service ExpansionThe U.S. continues expanding omics lab services for precision medicine, drug discovery, and translational research. Clients increasingly seek integrated genomics, proteomics, and metabolomics capabilities supported by advanced bioinformatics and scalable laboratory infrastructure.
Segment Leadership and Growth Trends
Omics Lab Services Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Repeat (Largest Segment) vs One-off (Fastest-Growing Segment)
The repeat segment held the largest share of the omics lab services market in 2026, supported by the recurring nature of genomic and molecular testing requirements across research, drug development, and clinical applications. Repeat engagements enable organizations to maintain ongoing access to specialized laboratory capabilities, supporting longitudinal studies, iterative research workflows, and continuous sample analysis. The increasing complexity of omics research and the need for consistent, high-quality analytical outputs further reinforce demand for recurring laboratory services.
The one-off segment is expanding rapidly as researchers, healthcare organizations, and biotechnology stakeholders increasingly seek specialized omics expertise for individual projects without establishing permanent in-house capabilities. One-off services offer flexibility for exploratory studies, targeted research programs, and projects requiring advanced technologies or specialized analytical skills. The growing accessibility of outsourced laboratory platforms is therefore supporting broader adoption among users with intermittent or project-specific testing requirements.
Services Segment Analysis: Genomics (Largest Segment) vs Epigenetics (Fastest-Growing Segment)
Genomics was the largest service segment in the omics lab services market in 2026, reflecting the broad applicability of genomic analysis across biomedical research, precision medicine, drug discovery, and disease investigation. Growing interest in genetic variation, sequencing, and molecular profiling continues to generate demand for specialized genomic laboratory capabilities. The increasing integration of genomic information into research and healthcare workflows further strengthens the segment's established position.
Epigenetics is the fastest-growing service segment, driven by increasing recognition of how gene regulation and environmental influences affect disease development and biological processes. Epigenetic analysis provides additional insights beyond genetic sequence information, making it valuable for cancer research, developmental studies, biomarker discovery, and therapeutic research. As researchers increasingly adopt multidimensional approaches to understand disease mechanisms, demand for specialized epigenetics laboratory services is gaining momentum.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | One-off, Repeat, Continuous | Repeat | One-off |
| Services | Genomics, Proteomics, Transcriptomic, Metabolomics, Epigenetics | Genomics | Epigenetics |
| End-Use | Hardware Equipment (Instrument, Kits, Chips), Testing / Lab (Services), Analytics / Interpretation (Personalization and Interpretation) | Hardware Equipment (Instrument, Kits, Chips) | Analytics / Interpretation (Personalization and Interpretation) |
| Business | Cancer, Pharmaco, Reproductive, Other Genetic Tests, Forensics, Population Studies, Skincare, Nutrition, Vitamins and Supplements, Genealogy, Others | Cancer | Skincare |
| Frequency of Service | Hospitals, Research Institutes, Diagnostic Labs | Research Institutes | Diagnostic Labs |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Leading companies in the omics lab services market:
1. Thermo Fisher Scientific Inc. (United States)
2. Illumina Inc. (United States)
3. QIAGEN N.V. (Netherlands)
4. Agilent Technologies Inc. (United States)
5. Quest Diagnostics Incorporated (United States)
6. BGI Genomics Co. Ltd. (China)
7. Laboratory Corporation of America Holdings (United States)
8. Eurofins Scientific SE (Luxembourg)
9. Q² Solutions (United States)
In the omics lab services market, integration of multi-omics platforms is enhancing research depth and analytical precision. Advanced sequencing and bioinformatics tools are enabling more comprehensive biological insights. The omics lab services market is also evolving through expanded service ecosystems supporting end-to-end research workflows. Continuous innovation is strengthening data interpretation capabilities.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Illumina Inc. (United States) | |||||||
| QIAGEN N.V. (Netherlands) | |||||||
| Agilent Technologies Inc. (United States) | |||||||
| Quest Diagnostics Incorporated (United States) | |||||||
| BGI Genomics Co. Ltd. (China) | |||||||
| Laboratory Corporation of America Holdings (United States) | |||||||
| Eurofins Scientific SE (Luxembourg) | |||||||
| Q² Solutions (United States). |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Omics Lab Services Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Workflow Stage | Sample Preparation, Sequencing/Assay, Data Processing, Bioinformatics & Interpretation |
| Sample Type | Blood & Plasma, Tissue, Saliva & Buccal Samples, Urine, Other Biological Samples |
| Technology Platform | Next-Generation Sequencing, Mass Spectrometry, Microarrays, PCR-Based Technologies, Other Platforms |
Omics Lab Services Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Precision Medicine Application Opportunities |
|
| Research Outsourcing Demand Analysis |
|
| Service Model Innovation and Digital Transformation |
|
Need a different cut of the data?
Request Custom ResearchHow big is the omics lab services market?
How will the omics lab services industry grow in terms of size and CAGR by 2036?
How is rising adoption of genomics and NGS technologies driving demand for outsourced omics lab services?
How is expanding oncology research and ctDNA analysis shaping clinical use of omics lab services?
Why are repeat services the largest segment in the omics lab services market?
Why is epigenetics the fastest-growing service segment?
Why does North America lead the omics lab services market?
How is Asia Pacific becoming the fastest-growing region in the omics lab services market?
Who are the major participants shaping the omics lab services landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization